
IPHA Stock Price Prediction
Innate Pharma SA
- Overview
- Forecast
- Valuation
- Earnings
1-Day-Price-Prediction
+0.16%
1-Week Prediction
+2.28%
Based on our advanced algorithm, we predict that IPHA stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $2.16, while the 1-week outlook suggests a value of $2.21. For the 1-month forecast, we project a price of $2.26. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
2.260
Should I Buy Innate Pharma SA Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. IPHA has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
IPHA stock price ended at $2.16 on Monday, after rising 2.86%
The Innate Pharma SA stock price increased by 2.86% on the last trading day (11 Aug 2025), rising from 2.18 to 2.16. Throughout the last trading session, the stock experienced a fluctuation of 2.85% , ranging from a day low of $2.1294 to a day high of 2.19. The price has declined in 5 of the last 10 days, resulting in a total change of -1.82% during this period. On the last day, trading volume increase by -2.26K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.26K shares were traded, amounting to approximately 7.13K.
IPHA Technical Signals
IPHA(Innate Pharma SA Corp) has 5 buy signals and 1 sell signal now. The current trend is downtrend starting from 2025-08-05. The total price change during this trend is +0.93%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of IPHA over the last 5 trading days is 8.86K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.

Get winning stock picks in minutes
IPHA Moving Average Analysis
Innate Pharma SA's overall moving average trend leans more bullish as of Monday, August 11, 2025, with 0 negative signals and 4 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $2.65, and $2.90. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.84, and $1.59. A break-down below any of these levels will issue sell signals.
IPHA Short Selling Analysis
The short sale ratio of Innate Pharma SA(IPHA) as of 08 Aug 2025 is 4.53%, dropping from last trading day. With decreasing price from 2.14 to 2.10. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary

Strong buy
Sell
1
Buy
5
Moving Average
Swing

Stock Price Above SMA_5
Short Term

SMA_5 Above SMA_20
Mid Term

SMA_20 Above SMA_60
Long Term

SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.204
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0678
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
Moving Average
Price crosses above 10-day SMA
--
Bullish
Moving Average
5-day SMA crosses above 10-day SMA
--
Bullish
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-0.04
Bearish
IPHA Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, Innate Pharma SA (IPHA) is anticipated to change hands in a trading channel between $0.00 and $0.00.
Innate Pharma SA Stock Forecast 2026

Get winning stock picks in minutes
IPHA Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Innate Pharma SA(IPHA), our algorithm predicts IPHA's 1-month price at $2.20, with an 4.95%upwardshift. Using a similarity score up to 98.16%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Innate Pharma SA (IPHA.O) stock, as of Sunday, August 10, 2025 , forecasts a 4.95% change over the next month, based on its high correlation with TG.N stock patterns. The similarity between their price movements over the analyzed periods is 98.16%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

IPHA
Future prediction
Up: 4.95%


Full Access. No Commitment.
7 Days Free!
AI Stock Picker
AI Swing Trade Signal
AI Earning Prediction
AI Screener
AI Financial Agent Help You Do Research
Already have an account? Sign In Here

TG
Up: 4.95%Similarity: 98.16%
Name
Similarity
Up/Down

TG.N
98.16%
+4.95%

CHMG.O
97.92%
-8.87%

CODI.N
97.82%
+0.63%

WHF.O
97.80%
+0.07%

CENT.O
97.79%
+14.58%

KLIC.O
97.75%
+16.65%

MERC.O
97.73%
+9.03%

GAIA.O
97.73%
-16.35%

CAR.O
97.73%
-12.35%

RDHL.O
97.72%
-6.32%
IPHA Seasonality Analysis
Based on IPHA's historical stock price data across all years, the probability of a positive return in August is50.00%, suggesting it maybe an ideal month to invest in IPHA. In contrast,Julyoffers the highest probability of positive returns at66.67%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Innate Pharma SA (IPHA.O) stock in July has the highest probability of a positive return (66.67%), while January has the lowest probability (16.67%).
Performance Seasonality
The chart shows Innate Pharma SA. (IPHA)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

TCRX
TScan Therapeutics Inc
1.610
USD
-1.83%

NOTV
Inotiv Inc
1.870
USD
+2.19%

LCUT
Lifetime Brands Inc
3.650
USD
-8.29%

CSBR
Champions Oncology Inc
6.380
USD
-0.47%

LTRX
Lantronix Inc
2.950
USD
-1.34%

SEER
Seer Inc
2.210
USD
-3.91%

FGBI
First Guaranty Bancshares Inc
8.000
USD
-0.87%

ACR
Acres Commercial Realty Corp
19.480
USD
-1.07%

SFBC
Sound Financial Bancorp Inc
46.240
USD
+0.39%

UNB
Union Bankshares Inc
26.280
USD
+0.31%
FAQ

Should I buy Innate Pharma SA (IPHA.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. IPHA has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

Which months have the highest win rate for buying Innate Pharma SA (IPHA.O) stock in a year?

How has Innate Pharma SA. (IPHA)'s stock price performed over the past three years?

Which bull technical signals does IPHA have?

Which bearish technical signals does IPHA have?

Is IPHA a buy based on overall technical signals summary?

What is the trend of Innate Pharma SA (IPHA)'s moving average?

What is price prediction for IPHA stock next month?

What is price prediction 2025 for IPHA Stock?
